Key result
Genetically predicted 1 kg increase in visceral adipose tissue links to ~30% higher ischemic stroke risk.
Why the study?
Obesity is linked to stroke risk, but whether visceral adipose tissue, the basis of central obesity, has a causal relationship with stroke remains to be explored.
Does increased visceral adipose tissue mass causally increase the risk of stroke?
Observational (n=443,354)
Mendelian randomization
Does increased visceral adipose tissue mass causally increase the risk of stroke?
Genetically predicted visceral adipose tissue mass is causally associated with an increased risk of ischemic stroke, particularly cardioembolic stroke, suggesting a potential target for genetic therapeutic strategies.
Should not change clinical stroke prevention; leaves open whether visceral fat reduction lowers ischemic stroke risk.
Purpose In recent years, metabolic syndrome has risen in prevalence and brought a heavy disease burden to modern society. As the representative aspect of metabolic syndrome, obesity has been shown to be related to an increased risk of stroke. Given that visceral adipose tissue (VAT) forms the fundamental basis of central obesity, we sought to explore a causal relationship between VAT and stroke by using mendelian randomization (MR) methods. Methods Based on two large genome-wide association studies (GWAS) including 325,153 and 35,762 cases of VAT and stroke, respectively, we conducted a MR study which has the inherent advantage of reducing the noise of confounding and reverse causation. Results VAT had a significant causal association with ischemic stroke (OR, per 1kg increase in VAT mass, 1.30; 95% CI, 1.18 ~ 1.45; P = 5.87E-07) as opposed to intracranial hemorrhage (ICH) (OR, 1.15; 95% CI, 0.70 ~ 1.88, P = 5.81E-01) as evaluated with inverse-variance weighting (IVW). Regarding subtypes of ischemic stroke, there was a significant causal effect for cardioembolic stroke (OR, 1.34; 95% CI, 1.13 ~ 1.58, P = 8.07E-04), and potential causal effect for small-vessel stroke (OR, 1.32; 95% CI, 1.06 ~ 1.65, P = 1.39E-02) and large-artery atherosclerotic stroke (OR, 1.33; 95% CI, 1.03 ~ 1.70, P = 2.59E-02). Conclusions This study provides potential evidence for a causal role of VAT in ischemic stroke and could suggest novel genetical therapeutic strategies for distinct subtypes of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) conducted an observational in Stroke (n=443,354). Visceral Adipose Tissue (VAT) mass was evaluated on Ischemic stroke (OR 1.30, 95% CI 1.18-1.45, p=5.87E-07). A genetically predicted 1 kg increase in visceral adipose tissue mass significantly increased the risk of ischemic stroke (OR 1.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: